Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
JHU395
i
Other names:
JHU395, JHU-395
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Dracen Pharma
Drug class:
Glutamine antagonist
Related drugs:
‹
DRP-104 (6)
JHU083 (0)
DRP-104 (6)
JHU083 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
MYC expression
Medulloblastoma
MYC expression
Medulloblastoma
JHU395
Sensitive: D – Preclinical
JHU395
Sensitive
:
D
JHU395
Sensitive: D – Preclinical
JHU395
Sensitive
:
D
NF1 mutation
Neurofibrosarcoma
NF1 mutation
Neurofibrosarcoma
DR6MP + JHU395
Sensitive: D – Preclinical
DR6MP + JHU395
Sensitive
:
D
DR6MP + JHU395
Sensitive: D – Preclinical
DR6MP + JHU395
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login